Lumasonix Inc.

[Available On-Demand] ・ Click video to start playback; Join chat Q&A below video
Search General Info
Lumasonix is focused on transforming cancer care through early detection. We are developing the first general cancer screening through the detection of circulating tumor cells (CTC’s) in blood. Tumors shed CTCs in blood as they grow, and through Photo-acoustic and Ultrasound imaging, we will detect their physical characteristics, classify and count the CTCs. This process will be fully automated to annually screen the US population with a low-cost test.
Speaker
photo
Vice President, Partnerships and Product
Lumasonix Inc.